FDA Grants Priority Review to Darzalex Combo Therapy for Relapsed Multiple Myeloma Patients
The U.S. Food and Drug Administration (FDA) is…
Myeloma
Myeloma overview
Myeloma is a rare blood cancer that begins in plasma cells, a type of white blood cell normally responsible for producing antibodies that help fight off infectious pathogens and other threats.
Read moreMyeloma treatment
While myeloma treatment can drive the disease into remission, sometimes for long periods of time, the cancer will often come back after a few months or years, and additional treatments will be needed.
Read moreLatest news
Study Furthers Knowledge of How Multiple Myeloma Cells Take Hold in Bone Marrow
The communication between multiple myeloma cells and healthy bone…
MMRF Opening Wealth of Myeloma Genomic Data to Researchers via NCI
The Multiple Myeloma Research Foundation (MMRF) is going…
Kyprolis Combo Fails to Outperform Velcade for Multiple Myeloma Patients Newly Diagnosed
Treatment of newly diagnosed multiple myeloma patients with a combination…
BioInvent Gets New Patent Protections for BI-505 as Possible Multiple Myeloma Treatment
BioInvent International has received further patent protection in China,…
Statin Use May Improve Survival in Newly Diagnosed Multiple Myeloma Patients
Newly diagnosed multiple myeloma patients who are using statins have…
